Physician profile
Bradley E Miller
NPI 1144499344
$3,029.89
in general payments reported to CMS, 2019-2025
24 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $173 · 2021: $501 · 2022: $615 · 2023: $385 · 2024: $278 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,014.23 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $279.36 | 2019-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $277.48 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $260.65 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Abbvie INC. | $174.13 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $168.83 | 2021-2022 | |
| Genzyme Corporation | $145.86 | 2021-2025 | |
| Abiomed | $145.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $141.34 | 2019-2021 | |
| Gilead Sciences, INC. | $103.00 | 2022-2024 | Veklury |
| Insmed, INC. | $44.58 | 2022-2025 | Brinsupri, Arikayce |
| United Therapeutics Corporation | $37.50 | 2021 | |
| Merck Sharp & Dohme LLC | $31.20 | 2024 | Winrevair |
| Amgen INC. | $28.73 | 2025 | Tezspire |
| Sunovion Pharmaceuticals INC. | $26.06 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $23.00 | 2024 | Hillrom - Monarch Airway Clearance System |
| Advanced Respiratory, INC | $21.32 | 2021 | |
| Circassia INC. | $18.49 | 2019 | |
| Mallinckrodt Enterprises LLC | $18.22 | 2019 | |
| Philips North America LLC | $16.59 | 2024 | (Ak6) Vest Therapy |
| Takeda Pharmaceuticals U.S.A., INC. | $15.13 | 2020 | |
| Abbott Laboratories | $14.13 | 2021 | |
| Pfizer INC. | $14.08 | 2025 | |
| Alexion Pharmaceuticals, INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.